Advances in Leiomyosarcoma Treatment Market: Trends and Future Outlook

Fri, 07 Feb 2025 11:00:06 +0000

The leiomyosarcoma treatment market comprises drugs utilized for treating leiomyosarcoma, which is a type of soft tissue cancer that develops in smooth muscle cells. Leiomyosarcoma most commonly occurs in the small intestine, esophagus, and uterus. Drugs used in the treatment of leiomyosarcoma include doxorubicin, gemcitabine, docetaxel, trabectedin. As there is no cure for leiomyosarcoma and existing therapies have limitations, drugs are primarily used for controlling tumor growth and relieving symptoms.